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n=10726! Over!50!years!n!(%)!n=1635! Prevalence!Ratio!(95%!Confidence!Interval)! pGvalue!Age!Median!(IQR)! 32.8!(29.0G36.1)! 54.1!(51.8G57.6)! ! !Male!gender! 3801!(35.4)! 771!(47.2)! 1.52!(1.39G1.66)! <0.05!Education!level!secondary!or!higher!! 6749!(84.5)! 602!(48.5)! 0.24!(0.22G0.27)! <0.05!Missing! 2739! 393! ! !Unemployed!! 5878!(54.8)! 860!(52.6)! 0.93!(0.85G1.01)! 0.10!Alcohol!user!! 1113!(11.5)! 152!(10.3)! 0.89!(0.76G1.05)! 0.17!Missing! 1070! 156! ! !Smoker!! 936!(9.7)! 191!(12.9)! 1.32!(1.15G1.15)! <0.05!Missing! 1082! 157! ! !Tuberculosis!at!initiation! 1633!(15.3)! 167!(10.2)! 0.67!(0.57G0.78)! <0.05!Missing! 20! 0! ! !Other!opportunistic!infection!at!initiation! 2502!(23.3)! 276!(16.9)! 0.70!(0.62G0.79)! <0.05!Other!AIDS!defining!condition!at!initiation!! 162!(1.5)! 29!(1.8)! 1.15!(0.82G1.61)! 0.42!WHO!Stage!III/IV!! 4635!(43.2)! 652!(39.9)! 0.89!(0.81G0.97)! <0.05!Body!Mass!Index!(BMI)!<18.5!! 1864!(22.4)! 272!(20.4)! 0.98!(0.86G1.12)! 0.78!BMI!18.5G24.9! 4797!(57.6)! 715!(53.6)! ! !BMI!>25.0! 1669!(20.0)! 347!(26.0)! 1.32!(1.18G1.49)! <0.05!Missing! 2396! 301! ! !Haemoglobin!<=10.0!g/dL! 2528!(28.4)! 321!(22.8)! 0.77!(0.69G0.87)! <0.05!Missing! 1812! 230! ! !Alanine!Transaminase!!>40!U/L! 1796!(21.3)! 237!(17.1)! 0.83!(0.73G0.95)! <0.05!Missing! 1859! 249! ! !Baseline!CD4+!0G100!cells/m3! 5590!(59.9)! 827!(56.3)! 0.71!(0.54G0.93)! <0.05!Missing! 1389! 165! ! !!Regimen!contains!nevirapine!(vs!efavirenz)! 1294!(12.1)! 60!(3.7)! 0.31!(0.24G0.40)! <0.05!Regimen!contains!zidovudine!(vs!stavudine)! 395!(3.7)! 82!(5.0)! 1.36!(1.11G1.66)! <0.05!Regimen!contains!tenofovir!(vs!stavudine)! 2106!(19.6)! 361!(22.1)! 1.16!(1.04G1.29)! <0.05!Guideline!period!after!1!April!2010!(vs!before!April!2010)*! 2184!(20.4)! 444!(27.2)! 1.38!(1.25G1.53)! <0.05!NonGART!drugs!associated!with!toxicity**! 1097!(10.2)! 192!(11.7)! 1.14!(0.99G1.31)! 0.06!NonGART!drugs!associated!with!drug!interaction**! 2422!(22.6)! 320!(19.6)! 0.85!(0.76G0.96)! <0.05!Polypharmacy!(>5!nonGART!medications)!noted**! 6232!(58.1)! 962!(58.8)! 1.03!(0.94G1.13)! 0.57!*!The!South!African!National!Department!of!Health!ART!guidelines!changed!on!this!date!from!1st!line!stavudineGcontaining!regimens!to!first!line!tenofovirGcontaining!regimens.!!**!These!drugs!are!listed!in!the!Appendix.!
#
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2.4.3.#Outcomes#after#12#months#of#ART#An!overview!of!the!treatment!outcomes!after!12!months!of!ART!is!provided!in!Table!2.!A!higher!proportion!of!the!older!patients!were!dead!(11.3%!vs!7.5%,!p!<0.05)!!compared!to!the!younger!patients.!There!was!no!difference!in!LTFU.!A!higher!proportion!in!the!older!group!were!transferred!out!!(6.2%!vs!4.3%,!p!<0.05).!In!the!older!group!proportionally!fewer!had!a!favourable!response!to!treatment!!(54.1%!vs!63.8%,!p!<0.05).!!This!was!due!to!less!having!adequate!CD4+!restoration!(62.8%!vs!75.0%,!p!<0.05);!however!more!older!patients!had!a!!suppressed!VL!(89.5%!vs!86.5%,!p!<0.05).!The!proportion!of!those!with!a!treatment!complication!was!similar!in!both!age!groups!(54.6%!vs!53.9%,!p!0.66).!!!!Table!2.!The!outcomes!after!12!months!of!ART!!! Category! 18G39.9!years! Over!50!years! Prevalence!Ratio!(95%!Confidence!interval)!
pGvalue!
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with#an#increased#risk#of#adverse#side#effects#in#HIV#infected#adults##(19)#!Drug!Class! Type! Examples!Anticholinergic! Antihistamines! chlorpheniramine!maleate,!loratadine,!promethazine!! Muscle!relaxants! baclofen,!orphenadrine!! AntiDparkinsons! biperidin!! Antiemetics! prochlorperazine!! Antispasmodics!! hyoscine!methylnitrate,!hyoscineDnDbutyl!bromide!! Antidepressants! amitriptyline,!amitriptyline!HCL,!imipramine,!paroxetine,!!! Antipsychotics! chlorpromazine!HCL,!fluphenazine!HCL!! Antimuscarinics! !Sedative! Benzodiazepines! alprazolam,!chlordiazepoxide,!clonazepam,!diazepam,!oxazepam,!!! Other!sedatives! phenobarbital,!zolpidem!tartrate!Baroreceptor! AlphaDblocker! doxazosin!mesylate!! BetaDblocker! atenolol,!propranolol!HCL,!Analgesics! Opioids! pethidine!HCL,!hydrocodone!bitartrate,!morphine!sulphate,!oxycodone!HCL!!!
3.2.#List#of#medications#used#in#the#TLC#cohort#that#commonly#
interact#with#ART#(19)#!Drug!class! Antiretroviral! Examples!!Anti!TB! PI/NNRTI! rifampicin!Antibiotic! PI/NNRTI! clarithromycin!Statin!! PI/NNRTI! simvastatin,!atorvastatin,!pravastatin!Antiepileptic!drugs! PI/NNRTI! phenytoin,!phenobarbital,!carbamazepine,!lamotrigine,!valproic!acid!Antihypertensive! PI/NNRTI! nifedipine,!amlodipine,!diltiazem,!felodopine!Corticosteroid! PI/NNRTI! Dexamethasone!Benzodiazepines! PI/NNRTI! midazolam,!alprazolam,!diazepam!Respiratory! PI! salmeterol,!sildenafil,!fluticasone!Migraine! PI/NNRTI! ergotamine!tartrate!!Antidepressant! PI! Amitriptyline!Miscellaneous! NNRTI! warfarin,!atovaquone!Miscellaneous! PI! colchicine,!atovaquone,!!!PID!Protease!Inhibitor!!NNRTID!NonDNucleoside!Reverse!Transcriptase!Inhibitor!
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